Acelyrin, Inc.
SLRN
$2.69
-$0.06-2.18%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 74.85M | 82.38M | 78.41M | 63.18M | 47.44M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 329.25M | 379.73M | 329.41M | 288.51M | 201.81M |
Operating Income | -329.25M | -379.73M | -329.41M | -288.51M | -201.81M |
Income Before Tax | -264.41M | -299.80M | -240.16M | -381.64M | -306.24M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -264.41 | -299.80 | -240.16 | -381.64 | -306.24 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -264.41M | -299.80M | -240.16M | -381.64M | -306.24M |
EBIT | -329.25M | -379.73M | -329.41M | -288.51M | -201.81M |
EBITDA | -328.92M | -379.48M | -329.25M | -246.53M | -137.07M |
EPS Basic | -2.68 | -3.06 | -2.60 | -10.85 | -19.93 |
Normalized Basic EPS | -1.90 | -2.20 | -1.91 | -2.64 | -8.26 |
EPS Diluted | -2.68 | -3.06 | -2.60 | -10.85 | -19.93 |
Normalized Diluted EPS | -1.90 | -2.20 | -1.91 | -2.64 | -8.26 |
Average Basic Shares Outstanding | 394.50M | 391.53M | 357.58M | 280.16M | 184.54M |
Average Diluted Shares Outstanding | 394.50M | 391.53M | 357.58M | 280.16M | 184.54M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |